Rowland Carmichael Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $411K | Buy |
3,834
+88
| +2% | +$9.43K | 0.13% | 170 |
|
|
2020
Q3 | $328K | Buy |
3,746
+30
| +0.8% | +$2.63K | 0.13% | 181 |
|
|
2020
Q2 | $365K | Buy |
3,716
+31
| +0.8% | +$3.05K | 0.16% | 162 |
|
|
2020
Q1 | $281K | Buy |
3,685
+213
| +6% | +$16.2K | 0.14% | 180 |
|
|
2019
Q4 | $307K | Hold |
3,472
| – | – | 0.11% | 218 |
|
|
2019
Q3 | $263K | Buy |
3,472
+431
| +14% | +$32.6K | 0.09% | 241 |
|
|
2019
Q2 | $221K | Hold |
3,041
| – | – | 0.08% | 248 |
|
|
2019
Q1 | $245K | Hold |
3,041
| – | – | 0.09% | 221 |
|
|
2018
Q4 | $280K | Hold |
3,041
| – | – | 0.12% | 181 |
|
|
2018
Q3 | $288K | Hold |
3,041
| – | – | 0.11% | 200 |
|
|
2018
Q2 | $282K | Sell |
3,041
-47
| -2% | -$4.36K | 0.12% | 202 |
|
|
2018
Q1 | $292K | Hold |
3,088
| – | – | 0.16% | 176 |
|
|
2017
Q4 | $299K | Sell |
3,088
-128
| -4% | -$12.4K | 0.15% | 178 |
|
|
2017
Q3 | $286K | Buy |
3,216
+128
| +4% | +$11.4K | 0.16% | 172 |
|
|
2017
Q2 | $224K | Sell |
3,088
-100
| -3% | -$7.25K | 0.13% | 200 |
|
|
2017
Q1 | $208K | Sell |
3,188
-500
| -14% | -$32.6K | 0.13% | 207 |
|
|
2016
Q4 | $231K | Sell |
3,688
-14,069
| -79% | -$881K | 0.14% | 205 |
|
|
2016
Q3 | $1.12M | Buy |
17,757
+924
| +5% | +$58.3K | 0.71% | 34 |
|
|
2016
Q2 | $1.04M | Buy |
16,833
+1,213
| +8% | +$75.1K | 0.66% | 40 |
|
|
2016
Q1 | $892K | Buy |
+15,620
| New | +$892K | 0.82% | 33 |
|